Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.

Eur J Med Chem 2015 Sep 14;102:631-8. Epub 2015 Aug 14.

College of Chemistry and Chemical Engineering, Jishou University, Jishou 416000, PR China; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, PR China. Electronic address:

Tyrosyl-tRNA synthetase (TyrRS), an essential enzyme in bacterial protein biosynthesis, is an attractive therapeutic target for finding novel antibacterial agents, and a series of N2-(arylacetyl)glycinanilides has been herein synthesized and identified as TyrRS inhibitors. These efforts yielded several compounds, with IC50 in the low micromolar range against TyrRS from Staphylococcus aureus. Out of the obtained compounds, 3ap is the most active and exhibits excellent activity against both Gram-positive (S. aureus) and Gram-negative (Escherichia coli and Pseudomonas aeruginosa) bacterial strains. In comparison with the parent scaffold 3-arylfuran-2(5H)-one, N2-(arylacetyl)glycinanilide significantly improved the potency against Gram-negative bacterial strains, indicating that this scaffold offers a significant potential for developing new antibacterial drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2015.08.025DOI Listing
September 2015
43 Reads

Publication Analysis

Top Keywords

bacterial strains
8
tyrosyl-trna synthetase
8
antibacterial agents
8
active exhibits
4
3ap active
4
compounds 3ap
4
aureus compounds
4
synthesized identified
4
exhibits excellent
4
gram-positive aureus
4
activity gram-positive
4
excellent activity
4
staphylococcus aureus
4
tyrrs staphylococcus
4
yielded compounds
4
efforts yielded
4
identified tyrrs
4
inhibitors efforts
4
compounds ic50
4
low micromolar
4

Similar Publications